Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that several MORU Network colleagues were honoured in the recent University of Oxford Recognition of Distinction rounds. Clockwise from top left: Joel Tarning was awarded the title of Professor of Clinical Pharmacology and Lisa White Professor of Modelling and Epidemiology. Stuart Blacksell, Susanna Dunachie, Paul Turner, Richard Maude, Frank Smithuis and Phaik Yeong Cheah were each awarded the title of Associate Professor.

Joel Tarning, Lisa White, Stuart Blacksell, Susie Dunachie, Phaik Yeong Cheah, Frank Smithuis, Richard Maude and Paul Turner

We are delighted to announce that several MORU Network colleagues were honoured in the recent University of Oxford Recognition of Distinction rounds. Clockwise from top leftJoel Tarning was awarded the title of Professor of Clinical Pharmacology and Lisa White Professor of Modelling and Epidemiology. Stuart BlacksellSusanna DunachiePaul TurnerRichard MaudeFrank Smithuis and Phaik Yeong Cheah were each awarded the title of Associate Professor.

In addition, two colleagues at LOMWRU, MORU’s Lao PDR unit, received significant recognition for their work: David Dance, LOMWRU’s Clinical Research Microbiologist and Unit Safety Officer, was made Honorary Professor at the London School of Hygiene and Tropical Medicine (LSHTM), and Dr Minivan Vongsouvath, Deputy Director of LOMWRU’s Microbiology Lab and Deputy Head of Virology, was recently awarded her MSc in Clinical Tropical Medicine from Mahidol University.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Peter Macharia wins RSTMH Emerging Leader Award

Peter Macharia is a spatial epidemiologist and a postdoc interested in disease mapping, healthcare access and mapping population vulnerabilities at KEMRI Wellcome. He received the RSTMH 2021 Emerging Leader Award, which recognises significant contributions in leadership, mentoring and capacity building in those who are early in their careers.

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

RECOVERY Trial paper on dexamethasone wins BMJ’s 2021 UK Research Paper of the Year Award

A RECOVERY Collaborative Group paper has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare. The paper, “Dexamethasone in Hospitalized Patients with Covid-19”, published in the New England Journal of Medicine, described the discovery in June 2020 of the world’s first effective, readily available treatment for COVID-19 – the inexpensive steroid, dexamethasone.

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.